ELVN — Enliven Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Twitter, Didi Global, Natus, Casa Systems
U.S. STOCKS ON THE MOVE-Twitter, Cryoport, Biogen, iSun, Synchrony Financial, Natus Medical
U.S. STOCKS ON THE MOVE-Boeing, Ocugen, Imara, RLX Technology, Ion Geophysical
Imara rises on workforce reduction
Brief: Imara Board Approves Reduction Of Co’s Workforce By 83% Across All Areas Of Co, To Total Of 6 Remaining Full-Time Employees
U.S. STOCKS ON THE MOVE-Mosaic, Advent Tech, COVID vaccine makers
U.S. STOCKS ON THE MOVE-NextDecade, U.S. banks, Hyzon Motors
U.S. STOCKS ON THE MOVE-Stellantis, Array, Big Tech
U.S. STOCKS ON THE MOVE-Gogo, JetBlue, Twitter
Brokerages downgrades Imara on uncertain future for lead drug
U.S. RESEARCH ROUNDUP- Acuity Brands, Bluebird Bio, Imara
U.S. STOCKS ON THE MOVE-PVH, Aterian, First Solar
U.S. STOCKS ON THE MOVE-System1, Domino's Pizza, Sunshine Biopharma
U.S. STOCKS ON THE MOVE-Twitter, Carnival, Imara
Imara slides on plans to stop blood disorder therapy development
Brief: Imara Announces Results Of Interim Analyses Of Tovinontrine Phase 2B Clinical Trials In Sickle Cell Disease And Beta-Thalassemia
U.S. RESEARCH ROUNDUP-Avalonbay Communities, Goodrx Holdings, Host Hotels & Resorts
Imara Inc reports results for the quarter ended in December - Earnings Summary
Brief: Imara Reports Full Year 2021 Financial Results And Business Highlights